Alnylam’s Vutrisiran Gains FDA Approval for Transthyretin Amyloidosis with Cardiomyopathy 1 year ago AnaIn Clinical TrialsFDA ApprovalsInnovation
Novartis Wins FDA Approval for Fabhalta as First and Only Oral Therapy for C3 Glomerulopathy 1 year ago AnaIn Clinical TrialsFDA ApprovalsInnovationTop Stories
FDA Clears First In Vivo Gene-Editing Therapy Trial for Chronic Hepatitis B in the US 1 year ago AnaIn Clinical TrialsFDA ApprovalsInnovationTop Stories
MaaT Pharma Announces Pivotal Phase 3 Success for Microbiome Therapy in Graft-versus-Host Disease 1 year ago AnaIn Clinical TrialsInnovationResearch Updates
Taiho Pharmaceutical Acquires Araris Biotech to Accelerate Next-Generation ADC Drug Development 1 year ago AnaIn InnovationPartnershipsPharma Industry UpdatesResearch Updates
Roche Presents Five-Year Data for SMA and Duchenne, Underscoring Impact of Gene and RNA Therapies 1 year ago AnaIn Biopharma HighlightsClinical TrialsInnovationTop Stories
Gilead Sciences Announces Breakthrough Data for Next-Generation HIV Therapy 1 year ago AnaIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
Regeneron and Sanofi Expand Immunology Pipeline with Novel Monoclonal Antibody Acquisition 1 year ago AnaIn Clinical TrialsInnovationPartnershipsPharma Industry Updates
Amgen’s New Studies Highlight Progress in Cardiovascular and Oncology Areas 1 year ago AnaIn InnovationPartnershipsPharma Industry Updates
Novo Nordisk and Regeneron Lead March with Groundbreaking Obesity and Cardiovascular Therapy Updates 1 year ago AnaIn Clinical TrialsPartnershipsPharma Industry UpdatesResearch Updates
Breakthroughs in Rare Disease Therapies and AI-Enabled Drug Discovery Mark March Biopharma News 1 year ago AnaIn InnovationPartnershipsResearch Updates
March 2025 Highlights: Biotech Deals, Clinical Advances, and Emerging Therapies 1 year ago AnaIn Funding RoundsPartnershipsPharma Industry UpdatesResearch UpdatesTop Stories
Sun Pharma Acquires Checkpoint Therapeutics to Expand Oncology and Immunotherapy Portfolio 1 year ago AnaIn Funding RoundsPartnershipsPharma Industry UpdatesTop Stories
AstraZeneca’s Billion-Dollar Acquisition and Strategic Deals Highlight March Biopharma M&A Boom 1 year ago AnaIn Funding RoundsPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Eli Lilly’s EBGLYSS Shows Sustained Skin Clearance at Three Years in Moderate-to-Severe Atopic Dermatitis 1 year ago AnaIn Biopharma HighlightsClinical TrialsInnovationTop Stories
